Mark Foletta
2020
In 2020, Mark Foletta earned a total compensation of $690K as Executive Vice President and Chief Financial Officer at Forte Biosciences, a 30% decrease compared to previous year.
Compensation breakdown
| Salary | $180,000 |
|---|---|
| Stock Awards | $51,275 |
| Other | $458,686 |
| Total | $689,961 |
Foletta received $458.7K in other compensation, accounting for 66% of the total pay in 2020.
Foletta also received $180K in salary and $51.3K in stock awards.
Rankings
In 2020, Mark Foletta's compensation ranked 10,016th out of 13,090 executives tracked by ExecPay. In other words, Foletta earned more than 23.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,016 out of 13,090 | 24th |
Division Manufacturing | 4,308 out of 5,624 | 23rd |
Major group Chemicals And Allied Products | 1,771 out of 2,257 | 22nd |
Industry group Drugs | 1,549 out of 1,957 | 21st |
Industry Pharmaceutical Preparations | 1,142 out of 1,462 | 22nd |
Source: SEC filing on April 30, 2021.
Foletta's colleagues
We found three more compensation records of executives who worked with Mark Foletta at Forte Biosciences in 2020.